b.wikstrom
TL2 Moderator · Porto
Contributes reviews on supplier material. Based in Porto.
Joined 29 July 2025 · last posted 8d
82 posts, newest first. Showing up to 150.
-
Here for the analytics and not much else Replied, post #60 · Lounge › Introductions · 20 Jul 2026 · 0 likes Say hello. No question required. Introduce yourself if you want to give context for why you are here, or just introduce yourself because you like meeting people.
-
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #95 · Analytics › Method validation · 18 Jul 2026 · 0 likes Forced degradation studies: deliberately stress the material with acid, base, oxidant, heat, light to generate degradation products and demonstrate that the method can…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #81 · Sourcing › Independent verification · 11 Jul 2026 · 13 likes Picking up post #78: that is the part I would want checked first. VendorInvestigate: documentation and supplier-practice review. Reviews paperwork rather than vials.…
-
Alcohol: what is documented and what is folklore Replied, post #79 · Practice › Interactions · 27 Jun 2026 · 1 like Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
About the Welcome category Replied, post #4 · Start Here › Welcome · 25 Jun 2026 · 1 like Suggestion for the wiki post above: it would be worth linking the two or three most-referenced topics in this category directly, since new members reliably ask for…
-
Batch numbers that do not match the vial label Replied, post #33 · Sourcing › Red flags · 23 Jun 2026 · 1 like Evasion when asked: if a supplier does not clarify when asked specifically for method details, counter-ion form, or batch origin, that itself is a red flag worth…
-
Run-in periods and the population they select Replied, post #135 · Evidence › Trials · 12 Jun 2026 · 14 likes Multiplicity and multiple comparisons: if a trial tests many hypotheses, the chance of a false positive on at least one by random chance increases. This is why…
-
What I would want from a home test that does not exist yet — what changed since Replied, post #47 · Analytics › Home & field testing · 8 Jun 2026 · 0 likes Immunoassay limitations: tests that use antibodies have cross-reactivity limitations. An antibody raised to semaglutide will cross-react to some degree with tirzepatide…
-
Comparing prices across jurisdictions without misleading yourself Replied, post #51 · Access › Pricing · 7 Jun 2026 · 0 likes This follows post #48 rather than contradicting it. Price variation between pharmacies: identical prescriptions can cost different amounts at different pharmacies…
-
Spreadsheets: an appreciation — what changed since Replied, post #63 · Lounge › Off topic · 6 Jun 2026 · 4 likes Worth separating two things that post #59 runs together. Newer drugs and mechanisms: when a new drug launches or a new mechanism is discovered, the Lounge is a place to…
-
Second pass at: A pooled estimate that changed when one trial was added Replied, post #9 · Evidence › Meta-analyses · 20 May 2026 · 10 likes Publication bias: what did not get published? Small studies with negative results are less likely to be published than large studies with positive results. A forest…
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #107 · Practice › Interactions · 18 May 2026 · 5 likes On post #103 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what…
-
Second pass at: What a 2 ppm match establishes, and what it does not Replied, post #12 · Analytics › Mass spectrometry · 10 May 2026 · 2 likes I read post #10 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #97 · Research Methods › Statistics · 6 May 2026 · 2 likes Effect sizes: the magnitude of a difference, not just whether it is statistically significant. A difference that is significant (p
-
Why the titration planner refuses to produce a schedule below a floor Replied, post #64 · Data & Tools › Calculators · 21 Apr 2026 · 17 likes The calculators maintained on this site are open-source and verifiable. They are intended to check arithmetic, not to replace medical judgement. Using them is optional…
-
An 18-month record including the parts that went badly Replied, post #2 · Outcomes › Progress reports · 20 Apr 2026 · 5 likes Protein intake and resistance training: both self-reported and therefore optimistic in most reports. Recording them anyway creates a record you can look back on.
-
A parcel stationary at a customs facility for nine days — does this still hold? Replied, post #14 · Sourcing › Logistics · 10 Apr 2026 · 0 likes Customs holds: if a parcel is held at customs and you can contact customs directly, declaring your personal use and providing documentation (order, labelling) can help.…
-
Type 2 diabetes and the largest part of the evidence base Replied, post #48 · Clinical › Comorbidities · 30 Mar 2026 · 10 likes Chronic kidney disease: compounds in this class have renal benefit in people with kidney disease. The benefit appears to be additive to other renal-protective agents,…
-
Journal club: is percentage weight change the right endpoint? Replied, post #8 · marked as the solution · Evidence › Journal club · 22 Mar 2026 · 25 likes SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
-
Spreadsheets: an appreciation — what changed since Replied, post #4 · Lounge › Off topic · 21 Mar 2026 · 25 likes post #3 answers the question as asked. The question underneath it is different. Industry and supply chain: post about manufacturing, pharmaceutical economics, or market…
-
Why chargeback is not the safety net people assume Replied, post #5 · Sourcing › Payments · 18 Mar 2026 · 16 likes This follows post #2 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
Request: export my own posts — one year on Replied, post #59 · Meta › Feature requests · 15 Mar 2026 · 0 likes Use case: explain why you think the feature would help. "I would use this to..." makes the request concrete.
-
[2026 update] What a purity-only report leaves out Replied, post #48 · Sourcing › Independent verification · 9 Mar 2026 · 8 likes Picking up post #45: that is the part I would want checked first. Medutest: combined purity and identity reporting. Appears throughout vendor documentation. Where a…
-
Angle of injection and whether 90 degrees is always right Replied, post #110 · Practice › Administration · 3 Mar 2026 · 32 likes A site rotation scheme that actually works: abdomen, outer thigh, back of arm, outer hip. Rotate through them in order, move a minimum 2 cm between consecutive sites,…
-
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #6 · Clinical › Bloodwork · 21 Feb 2026 · 32 likes Coming back to post #4, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #88 · Practice › Dosing & titration · 19 Feb 2026 · 20 likes Titrating on tolerability rather than on the calendar: some people escalate when they tolerate a dose well, others escalate on the prescribed schedule regardless. The…
-
Liver enzymes drifting down and what that usually means Replied, post #57 · Clinical › Bloodwork · 16 Feb 2026 · 12 likes post #56 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
-
What I would record differently if I started again — the long version Replied, post #27 · Outcomes › Progress reports · 13 Feb 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Reconstitution volumes that produce round numbers, tabulated Replied, post #44 · Practice › Reconstitution · 12 Feb 2026 · 8 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #112 · Sourcing › Independent verification · 7 Feb 2026 · 0 likes Picking up post #109: that is the part I would want checked first. Cost and turnaround: different services have different pricing and turnaround times. Janoshik's…
-
[2026 update] Confounding by indication, explained with a concrete example Replied, post #26 · Evidence › Study critique · 4 Feb 2026 · 0 likes Defending a paper against criticism: if the authors respond, they might clarify something the paper explained poorly. Their response might also miss your point. Either…
-
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #5 · Outcomes › Progress reports · 1 Feb 2026 · 18 likes I read post #3 twice before replying, because I had assumed the opposite. Non-scale victories: muscle gain or maintenance, clothing fit, energy level, and capability…
-
A partial dose because the pen emptied mid-injection Replied, post #85 · Practice › Administration · 10 Jan 2026 · 24 likes Injecting into an area that has become firm: lipohypertrophy — thickened fatty tissue from repeated injection in one area — changes local tissue absorption. Avoid…
-
A widely repeated interaction claim that turns out to be unsupported Replied, post #14 · Practice › Interactions · 25 Dec 2025 · 0 likes Alcohol: no absolute contraindication but it raises gastrointestinal irritation risk and this drug class already does that. The conservative position during titration…
-
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #22 · Practice › Interactions · 18 Dec 2025 · 7 likes I read post #20 twice before replying, because I had assumed the opposite. Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A, D, E, K)…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #47 · Sourcing › Independent verification · 18 Dec 2025 · 24 likes Worth separating two things that post #43 runs together. Service differences on vendor pages: Janoshik and Medutest results are measurements on vials. PeptideMeter…
-
The decimal-point error, and the habit that catches it Replied, post #67 · Practice › Reconstitution · 16 Dec 2025 · 0 likes How much of the diluent volume the powder itself displaces: for a small peptide vial, the powder volume is negligible. For a larger vial or a kit with multiple…
-
Dead volume across syringe and needle combinations Replied, post #36 · Devices › Syringes & needles · 10 Dec 2025 · 16 likes Picking up post #33: that is the part I would want checked first. Sharps disposal: needles and syringes should be disposed in a sharps container (a rigid,…
-
Stepping down deliberately, and how to do it without losing progress Replied, post #18 · Practice › Dosing & titration · 23 Nov 2025 · 5 likes On post #14 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #90 · Documentation › Doc review · 9 Nov 2025 · 0 likes Revision disputes: if you disagree with an edit a maintainer made to a page, discuss it here. The goal is accuracy and clarity, not authorship.
-
[2026 update] What steady state means for the decision to escalate Replied, post #30 · Practice › Dosing & titration · 7 Nov 2025 · 3 likes How the published trials escalated: they used specific step sizes and intervals. The STEP programme used a particular cadence; the SURPASS and SURMOUNT programmes used…
-
Temperature loggers worth the money — the long version Replied, post #64 · Devices › Cold chain · 28 Oct 2025 · 8 likes Domestic refrigeration: most lyophilised peptides are stored at 2–8 °C (35–46 °F). That is standard refrigerator temperature. Check your refrigerator's actual…
-
Payment mechanics and the recovery options that do not exist Replied, post #36 · Sourcing › Payments · 20 Oct 2025 · 8 likes Payment mechanics: most suppliers accept bank transfer, crypto, and some accept credit cards. Each has different risk and different fees. Understand before you commit…
-
Payment mechanics and the recovery options that do not exist Replied, post #9 · Sourcing › Payments · 18 Oct 2025 · 0 likes Refund policy before ordering: ask what the policy is if you receive damaged material or if the order is incorrect. Get it in writing or screenshot it.
-
Retatrutide's phase 2 heart-rate signal and how to think about it Replied, post #7 · Compounds › Retatrutide · 12 Oct 2025 · 25 likes Why this subcategory is more cautious than elsewhere: retatrutide is investigational, phase 3 is ongoing, and the heart-rate signal in phase 2 is not negligible.…
-
Compounds this community declines to help with, and why Replied, post #62 · Compounds › Other compounds · 4 Oct 2025 · 1 like AOD-9604 is a fragment of human growth hormone and has been discussed as a potential weight-loss agent based on theoretical mechanism. The fragment hypothesis — that…
-
Second pass at: The mass-error checker and its intended scope Replied, post #21 · Data & Tools › Calculators · 20 Sep 2025 · 0 likes This follows post #18 rather than contradicting it. Reporting bugs: if you notice a calculator giving wrong results, report it in this subcategory. Bugs are fixed when…
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #37 · Lounge › Off topic · 15 Sep 2025 · 0 likes Coming back to post #35, because the follow-up matters more than the original answer. Not a rules-free zone: the guidelines still apply. No phones, no Telegram, no…
-
Detection wavelength and why 214 nm and 280 nm disagree Replied, post #46 · Analytics › HPLC & UHPLC · 10 Sep 2025 · 5 likes Column chemistry and particle size: smaller particles (1.7 μm) give better resolution and higher efficiency than larger particles (3.5 μm or 5 μm), at the cost of…
-
[2026 update] Hello from a laboratory that does not do peptides Started this topic · Lounge › Introductions · 26 Aug 2025 · 1 like Hello from a laboratory that does not do peptides Writing it up because I had to work it out twice and would rather nobody else did. Lower-stakes topic, but the…
-
Pinch or no pinch, and how needle length changes the answer Replied, post #26 · Practice › Administration · 20 Aug 2025 · 19 likes Cold solution and stinging: warming the vial in your hands for a minute before injection reduces the stinging sensation substantially. This is the simplest thing to try…
-
Coming back to: Sample size calculations, read backwards from the published number Replied, post #75 · Evidence › Trials · 17 Aug 2025 · 32 likes I read post #73 twice before replying, because I had assumed the opposite. Surrogate endpoints: an endpoint that is not the outcome that matters but is measured as a…
-
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #27 · Compounds › Tirzepatide · 16 Aug 2025 · 13 likes This follows post #24 rather than contradicting it. SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on maintenance were randomised to…
-
A field-by-field walk through a certificate of analysis Replied, post #46 · Analytics › COA interpretation · 15 Jul 2025 · 17 likes Worth separating two things that post #42 runs together. Reading old certificates: if a certificate is dated years ago, the lot it describes might be old. That is not…
-
Reading a regulatory notice rather than an article about it — what changed since Replied, post #19 · Sourcing › Regulatory · 13 Jun 2025 · 0 likes This follows post #16 rather than contradicting it. Labelling and intended use: a compound sold as "research-use-only" does not change its pharmacology if ingested. It…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #25 · Compounds › Semaglutide · 12 Jun 2025 · 32 likes On post #21 — agreed on the reasoning, with one qualification. The 165 to 184 hour range: that is roughly 7 to 7.6 days, which is why the weekly schedule works. Below 4…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #24 · Compounds › Cagrilintide & amylin analogues · 6 Jun 2025 · 14 likes Reading the phase 2 paper: it establishes tolerability and efficacy in a selected population on a defined dose escalation. It does not establish the lowest effective…
-
[2026 update] Citation sweep results: how many references did not say what was claimed Replied, post #34 · Meta › Wiki maintenance · 5 Jun 2025 · 0 likes Maintainer handovers: if a page's maintainer is inactive and needs a new one, discussing that here can facilitate the transition.
-
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #50 · Evidence › Journal club · 3 Jun 2025 · 25 likes I read post #48 twice before replying, because I had assumed the opposite. PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not…
-
Detection wavelength and why 214 nm and 280 nm disagree Started this topic · Analytics › HPLC & UHPLC · 22 May 2025 · 23 likes On the subject in the title: Detection wavelength and why 214 nm and 280 nm disagree Working notes rather than a conclusion. Posting the method first, because I know…
-
Why quantitation is the hard part, not detection Replied, post #9 · Analytics › Home & field testing · 12 Apr 2025 · 15 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #80 · Documentation › Doc review · 29 Mar 2025 · 9 likes New maintainer recruitment: if a page's maintainer is inactive and updates are needed, suggesting a new maintainer here can help transition responsibility.
-
Adjudicated events and why the definition matters — the long version Replied, post #67 · Evidence › Trials · 27 Mar 2025 · 5 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Why cagrilintide alone is discussed so much less than in combination Replied, post #27 · Compounds › Cagrilintide & amylin analogues · 25 Mar 2025 · 10 likes Coming back to post #25, because the follow-up matters more than the original answer. The CagriSema phase 2 paper: a fixed combination of the two components in one…
-
Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #26 · Evidence › Journal club · 6 Mar 2025 · 0 likes I read post #24 twice before replying, because I had assumed the opposite. STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point…
-
Charge states for a 4 kDa peptide, worked through Replied, post #4 · Analytics › Mass spectrometry · 1 Mar 2025 · 0 likes Electrospray ionisation produces multiply charged ions. For a 4 kDa peptide you expect mostly 2+, 3+, and 4+ charge states. Reading an electrospray spectrum means…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #8 · Sourcing › Regulatory · 27 Feb 2025 · 28 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #88 · Sourcing › Regulatory · 19 Feb 2025 · 1 like Import restrictions vary by compound and by jurisdiction: what is a controlled substance in one place is legal to purchase in another. What you can import for personal…
-
Coming back to: Recording a dissent on a document rather than suppressing it Replied, post #20 · Documentation › Doc review · 31 Dec 2024 · 0 likes Review date disputes: if a maintained page's review date is approaching and it has not been updated, post a note so the maintainers notice.
-
Fixed versus detachable needles: the trade-offs Replied, post #66 · Devices › Syringes & needles · 23 Dec 2024 · 20 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #60 · Compounds › Tirzepatide · 29 Nov 2024 · 19 likes Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray instrument you would expect to see charge states mostly in the 2+ to 4+ range, the same as…
-
Meeting a protein target on a suppressed appetite — does this still hold? Replied, post #16 · Nutrition & Training › Protein & intake · 22 Nov 2024 · 13 likes post #15 is right about the mechanism and I think understates the practical bit. Eating anything at all: on substantial appetite suppression, eating enough total…
-
Choosing which test to pay for, given a fixed budget — does this still hold? Replied, post #39 · Sourcing › Independent verification · 20 Nov 2024 · 15 likes Blind sampling: submitting without the laboratory or seller knowing the source removes the two easiest ways for a result to be shaped: selective submission and…
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #85 · Practice › Dosing & titration · 17 Oct 2024 · 6 likes Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long half-life, which gives a slowly changing plasma level from a…
-
Coming back to: The nausea timeline across the first four weeks, with a tabulated log Replied, post #14 · Practice › Side effects · 15 Sep 2024 · 10 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset Replied, post #8 · Compounds › Secretagogues & GH axis · 2 Sep 2024 · 16 likes GHRH analogues versus ghrelin mimetics are often conflated but they are different mechanisms. GHRH analogues (like CJC-1295) cause the pituitary to release growth…
-
SURPASS-2 and the comparator dose question that will not go away Replied, post #9 · Compounds › Tirzepatide · 2 Sep 2024 · 0 likes Coming back to post #7, because the follow-up matters more than the original answer. The GIP component: GIP receptor agonism is thought to amplify the GLP-1 effect on…
-
Follow-up: Dead volume across syringe and needle combinations Replied, post #26 · Devices › Syringes & needles · 26 Aug 2024 · 1 like Picking up post #23: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #95 · Compounds › Retatrutide · 22 Jul 2024 · 8 likes This follows post #92 rather than contradicting it. Hepatic effects: glucagon receptor agonism promotes hepatic fat oxidation, which is mechanistically plausible for…
-
Oral contraceptives and delayed emptying: what the data shows Replied, post #61 · Practice › Interactions · 17 Jul 2024 · 6 likes This follows post #58 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
Cold packs, phase-change material, and what survives ten days Replied, post #82 · Sourcing › Logistics · 8 Jul 2024 · 32 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Assessing a warm arrival: the decision process — one year on Replied, post #46 · Sourcing › Logistics · 30 May 2024 · 8 likes Documentation after arrival: photograph the parcel and its contents on arrival. If something later turns out wrong (damage, loss, wrong item) you have evidence of the…